Research graph
References from Multi‐Omics Integration Reveals Metabolic Reprogramming and EMT ‐Driven Metastasis in Triple‐Negative Breast Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Recent Advances in Therapeutic Strategies for Triple‐Negative Breast Cancer
10.1186/s13045-022-01341-0 · 2022 · External reference
Treatment Landscape of Triple‐Negative Breast Cancer ‐ Expanded Options, Evolving Needs
10.1038/s41571-021-00565-2 · 2022 · External reference
Triple‐Negative Breast Cancer Therapeutic Resistance: Where Is the Achilles' Heel?
10.1016/j.canlet.2020.10.016 · 2021 · External reference
Tumor Microenvironment: Challenges and Opportunities in Targeting Metastasis of Triple Negative Breast Cancer
10.1016/j.phrs.2020.104683 · 2020 · External reference
Therapeutic Targets in Triple Negative Breast Cancer Where Are We Now?
10.2174/157489211795328521 · 2011 · External reference
An Insight Into Molecular Targets of Breast Cancer Brain Metastasis
10.3390/ijms231911687 · 2022 · External reference
Crosstalk Between Cancer‐Associated Fibroblasts and Immune Cells in the Tumor Microenvironment: New Findings and Future Perspectives
10.1186/s12943-021-01428-1 · 2021 · External reference
Stromal Characteristics and Impact on New Therapies for Metastatic Triple‐Negative Breast Cancer
10.3390/cancers14051238 · 2022 · External reference
Epithelial‐Mesenchymal Transition and Tumor‐Associated Macrophage Axis in Metastatic Breast Cancer: Converging Mechanisms and Therapeutic Perspectives
10.1016/j.lfs.2025.124084 · 2026 · External reference
DNA Methylation and Immune Evasion in Triple‐Negative Breast Cancer: Challenges and Therapeutic Opportunities
10.3389/fonc.2025.1534055 · 2025 · External reference
The lncRNA AFAP1‐AS1 Is Upregulated in Metastatic Triple‐Negative Breast Tumors and Controls Hypoxia‐Activated Vasculogenic Mimicry and Angiogenesis
10.1186/s12885-024-13019-6 · 2024 · External reference
Metabolic Reprogramming in Triple‐Negative Breast Cancer
10.20892/j.issn.2095-3941.2019.0210 · 2020 · External reference
Distinct Tumor Architectures and Microenvironments for the Initiation of Breast Cancer Metastasis in the Brain
10.1016/j.ccell.2024.08.015 · 2024 · External reference
The Technological Landscape and Applications of Single‐Cell Multi‐Omics
10.1038/s41580-023-00615-w · 2023 · External reference
Single‐Cell Transcriptomic Analysis Reveals the Landscape of Epithelial‐Mesenchymal Transition Molecular Heterogeneity in Esophageal Squamous Cell Carcinoma
10.1016/j.canlet.2024.216723 · 2024 · External reference
Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective
10.3390/pathophysiology29020017 · 2022 · External reference
Immune Monitoring Using Mass Cytometry and Related High‐Dimensional Imaging Approaches
10.1038/s41584-019-0338-z · 2020 · External reference
The COSMIC Cancer Gene Census: Describing Genetic Dysfunction Across All Human Cancers
10.1038/s41568-018-0060-1 · 2018 · External reference
Single‐Cell Analysis by Mass Cytometry Reveals Metabolic States of Early‐Activated CD8(+) T Cells During the Primary Immune Response
10.1016/j.immuni.2021.02.018 · 2021 · External reference
Spatial Predictors of Immunotherapy Response in Triple‐Negative Breast Cancer
10.1038/s41586-023-06498-3 · 2023 · External reference
Breast Tumor Microenvironment Structures Are Associated With Genomic Features and Clinical Outcome
10.1038/s41588-022-01041-y · 2022 · External reference
UDP‐Glucose Dehydrogenase Expression Is Upregulated Following EMT and Differentially Affects Intracellular Glycerophosphocholine and Acetylaspartate Levels in Breast Mesenchymal Cell Lines
10.1002/1878-0261.13172 · 2022 · External reference
Nucleotide Metabolism: A Pan‐Cancer Metabolic Dependency
10.1038/s41568-023-00557-7 · 2023 · External reference
Distinct Metabolic Dependency on BCAA Defines Cancer Stemness and Malignancy in Human Triple‐Negative Breast Cancer
10.1016/j.celrep.2026.117630 · 2026 · External reference
Amino Acid Metabolism in Breast Cancer: Pathogenic Drivers and Therapeutic Opportunities
10.1093/procel/pwaf011 · 2025 · External reference
The Taurine‐Slc6a6 Axis Promotes Breast Cancer Progression by Alleviating Oxidative Stress and Accelerating Cell Cycle Progression
10.3390/cells15020207 · 2026 · External reference
Modeling the Role of Cancer‐Associated Fibroblasts in Tumor Cell Invasion
10.3390/cancers14040962 · 2022 · External reference
Multi‐OMICS Approaches in Cancer Biology: New Era in Cancer Therapy
10.1016/j.bbadis.2024.167120 · 2024 · External reference
The Epithelial‐Mesenchymal Transition at the Crossroads Between Metabolism and Tumor Progression
10.3390/ijms23020800 · 2022 · External reference
The Molecular Mechanisms and Therapeutic Strategies of EMT in Tumor Progression and Metastasis
10.1186/s13045-022-01347-8 · 2022 · External reference
Emerging Mechanisms by Which EMT Programs Control Stemness
10.1016/j.trecan.2020.03.011 · 2020 · External reference
Wnt/Beta‐Catenin Mediated Signaling Pathways in Cancer: Recent Advances, and Applications in Cancer Therapy
10.1186/s12943-025-02363-1 · 2025 · External reference
The Role of Tumor Epithelial‐Mesenchymal Transition and Macrophage Crosstalk in Cancer Progression
10.1007/s11914-023-00780-z · 2023 · External reference
EMT, MET, Plasticity, and Tumor Metastasis
10.1016/j.tcb.2020.07.003 · 2020 · External reference
Metabolic Reprogramming and Cancer Progression
10.1126/science.aaw5473 · 2020 · External reference
Branched‐Chain Amino Acid and Cancer: Metabolism, Immune Microenvironment and Therapeutic Targets
10.1186/s12967-025-06664-3 · 2025 · External reference
Cancer Metabolism: Looking Forward
10.1038/s41568-021-00378-6 · 2021 · External reference
Focus on the Glycerophosphocholine Pathway in Choline Phospholipid Metabolism of Cancer
10.1002/nbm.4112 · 2019 · External reference
Metabolic Reprogramming of Cancer‐Associated Fibroblasts and Its Effect on Cancer Cell Reprogramming
10.7150/thno.62378 · 2021 · External reference
Microenvironmental Regulation of Tumor Progression and Metastasis
10.1038/nm.3394 · 2013 · External reference
TGFbeta Drives Immune Evasion in Genetically Reconstituted Colon Cancer Metastasis
10.1038/nature25492 · 2018 · External reference
Spatial Multiomics of the Breast Tumour Microenvironment: State of the Field, Advancements and Clinical Implementation Promises
10.1016/j.critrevonc.2025.105082 · 2026 · External reference
Clinical and Therapeutic Relevance of Cancer‐Associated Fibroblasts
10.1038/s41571-021-00546-5 · 2021 · External reference
Targeting Metastatic Cancer
10.1038/s41591-020-01195-4 · 2021 · External reference
Single‐Cell Multi‐Omics in Cancer Immunotherapy: From Tumor Heterogeneity to Personalized Precision Treatment
10.1186/s12943-025-02426-3 · 2025 · External reference
